BPC-157, a synthetic peptide first developed to treat gastrointestinal injuries in pigs , has ignited considerable interest within the health community. Experts believe it possesses impressive potential to encourage tissue repair , alleviate pain, and even accelerate wound healing. While investigations on people remain restricted, preliminary